Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer.

Literature DB >> 31392161

Significant lack of urine-based biomarkers to replace cystoscopy for the surveillance of non-muscle invasive bladder cancer.

Makito Miyake¹, Takuya Owari¹, Shunta Hori¹, Kiyohide Fujimoto¹.

Abstract

Entities: Disease

Year: 2019 PMID： 31392161 PMCID： PMC6642949 DOI： 10.21037/tau.2019.05.07

Source DB: PubMed Journal: Transl Androl Urol ISSN： 2223-4683

× No keyword cloud information.

11 in total

1. A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma: A prospective study.

Authors: Ana B Galván; Marta Salido; Blanca Espinet; José Placer; Lara Pijuan; Núria Juanpere; Josep Lloreta; Francesc Solé; Antoni Gelabert-Mas
Journal: Cancer Cytopathol Date: 2011-06-29 Impact factor: 5.284

2. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.

Authors: Yair Lotan; Paul OʼSullivan; Jay D Raman; Sharokh F Shariat; Laimonis Kavalieris; Chris Frampton; Parry Guilford; Carthika Luxmanan; James Suttie; Henry Crist; Douglas Scherr; Scott Asroff; Evan Goldfischer; Jeffrey Thill; David Darling
Journal: Urol Oncol Date: 2017-03-31 Impact factor: 3.498

3. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models.

Authors: Lourdes Mengual; María José Ribal; Juan José Lozano; Mercedes Ingelmo-Torres; Moisés Burset; Pedro Luís Fernández; Antonio Alcaraz
Journal: J Urol Date: 2013-07-02 Impact factor: 7.450

4. Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.

Authors: Takahiro Kojima; Hiroyuki Nishiyama; Seiichiro Ozono; Shiro Hinotsu; Naoto Keino; Akito Yamaguchi; Hideki Sakai; Yutaka Enomoto; Shigeo Horie; Kiyohide Fujimoto; Hideyasu Matsuyama; Takehiko Okamura; Yusuke Kanimoto; Mototsugu Oya; Norio Nonomura; Seiji Naito; Hideyuki Akaza
Journal: Int J Clin Oncol Date: 2018-07-03 Impact factor: 3.402

5. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.

Authors: Lourdes Mengual; Moisès Burset; María José Ribal; Elisabet Ars; Mercedes Marín-Aguilera; Manuel Fernández; Mercedes Ingelmo-Torres; Humberto Villavicencio; Antonio Alcaraz
Journal: Clin Cancer Res Date: 2010-04-20 Impact factor: 12.531

6. Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer.

Authors: Makito Miyake; Kokichi Sugano; Hitomi Sugino; Kazuho Imai; Eri Matsumoto; Koshi Maeda; Shinich Fukuzono; Hiroki Ichikawa; Kiyotaka Kawashima; Kaoru Hirabayashi; Tetsuro Kodama; Hiroyuki Fujimoto; Tadao Kakizoe; Yae Kanai; Kiyohide Fujimoto; Yoshihiko Hirao
Journal: Cancer Sci Date: 2009-09-01 Impact factor: 6.716

7. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing.

Authors: Tine Hajdinjak
Journal: Urol Oncol Date: 2008-01-15 Impact factor: 3.498

8. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.

Authors: Maria J Ribal; Lourdes Mengual; Juan J Lozano; Mercedes Ingelmo-Torres; Joan Palou; Oscar Rodríguez-Faba; Johannes A Witjes; Antoine G Van der Heijden; Rafael Medina; Jose M Conde; Michael Marberger; Joerg Schmidbauer; Pedro L Fernández; Antonio Alcaraz
Journal: Eur J Cancer Date: 2016-01-04 Impact factor: 9.162